Frank Jaeger is Chief Commercial Officer of Clarus Therapeutics Holdings, Inc.. Currently has a direct ownership of 29,000 shares of CRXT, which is worth approximately $870. The most recent transaction as insider was on Dec 11, 2021, when has been sold 29,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29K
0% 3M change
0% 12M change
Total Value Held $870

Frank Jaeger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2021
BUY
Grant, award, or other acquisition
-
29,000 Added 50.0%
29,000 Common Stock
FJ

Frank Jaeger

Chief Commercial Officer
Northbrook, IL

Track Institutional and Insider Activities on CRXT

Follow Clarus Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRXT shares.

Notify only if

Insider Trading

Get notified when an Clarus Therapeutics Holdings, Inc. insider buys or sells CRXT shares.

Notify only if

News

Receive news related to Clarus Therapeutics Holdings, Inc.

Track Activities on CRXT